Navigation Links
Gen-Probe Announces Webcasts of Three Upcoming Investor Events
Date:10/13/2008

- Third Quarter 2008 Earnings Conference Call on October 30 -

- Presentation at Oppenheimer's 19th Annual Healthcare Conference on

November 4 - - Annual Analyst Day for Institutional Investors and Financial Analysts on

November 7 -

SAN DIEGO, Oct. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will webcast three upcoming investor events.

First, Gen-Probe will release its third quarter 2008 financial results on Thursday, October 30, 2008 at approximately 4:00 pm Eastern Time (ET), followed by a conference call with management at 4:30 pm ET. The conference call will be webcast live and may be accessed on the investors section of the Company's web site at http://www.gen-probe.com. An archived version of the webcast will be available on the same web site for at least 90 days. A telephone replay also will be available for 24 hours after the call ends. To access the replay, please call 866-505-9257 (US) or 203-369-1881 (international).

Second, the Company will present at Oppenheimer's 19th Annual Healthcare Conference in New York on Tuesday, November 4, 2008 at 12:40 pm ET. The presentation is scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website. The webcast will be available for 30 days following the event.

Third, Gen-Probe will webcast its annual meeting with institutional investors and sell-side analysts in San Diego on Friday, November 7, 2008, at 8 am Pacific Time (11 am ET). The meeting, which will feature presentations on Gen-Probe's current business and future growth strategies, will conclude at approximately 11 am Pacific Time (2 pm ET). Institutional investors and sell-side analysts can RSVP to attend in person by contacting Paula Izidoro at paulai@gen-probe.com. Please note the new date and time. Others may access a live webcast through a link on the investors section of Gen-Probe's website. The webcast will be available for 30 days following the event.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the period ended June 30, 2008, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro

Investor Relations

858-410-8904


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Gen-Probe to Webcast Two Upcoming Investor Presentations
2. Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
3. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
4. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
5. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
6. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
7. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
8. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
9. Texas Back Institute Announces Nine for Your Spine for National Spine Health Day - October 16
10. CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008
11. RF Technologies(R) Announces Code Alert(R) Integrated Care Management Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... GrassrootsHealth ... incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially higher ... make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, “the ...
(Date:2/8/2016)... Las Vegas, Nevada (PRWEB) , ... February 08, ... ... Co-Founder at RowdMap, Inc., will be speaking on how healthcare companies can use ... project costs, manage the health of a population and intervene and capture the ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by ... require dental technicians to be certified or obtain continuing education. To increase patient ... “What’s In Your Mouth?” campaign to inform dentists and patients about the possible ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... MyDecision™ empowers employers and organizations with the tools and information to lower the ... elements to cut the cost of providing employee healthcare benefits by as much ...
(Date:2/6/2016)... ... ... US Sports Camps is proud to sponsor the Bay Area Disc Association's ... leaders, ultimate organizations, and coaches from around the US. The theme for this year’s ... of Youth and Education, describes this year YUCC as “an important conversation we must ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... DURHAM, N.C. , Feb. 8, 2016  Avista ... appointed Eric Setzer as Chief Financial Officer (CFO). ... over twenty years of experience in various roles within ... Avista Pharma, he served as the Executive Director of ... organization in Raleigh, NC . Previously, ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
(Date:2/8/2016)... 2016 Palatin Technologies, Inc. (NYSE MKT: ... therapeutics for the treatment of diseases with significant ... that the United States Patent and Trademark Office ... U.S. Patent Application Serial Number 14/313,258 (the ,258 ... treating female sexual dysfunction using the formulation and ...
Breaking Medicine Technology: